PND39 A COST-EFFECTIVENESS ANALYSIS OF PREGABALIN VS. DULOXETINE IN THE TREATMENT OF FIBROMYALGIA IN CHINA
Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.1809
https://www.valueinhealthjournal.com/article/S1098-3015(19)34187-7/fulltext
Section Title :
Section Order :
11574
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)34187-7&doi=10.1016/j.jval.2019.09.1809